GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Beneish M-Score

Dian Diagnostics Group Co (SZSE:300244) Beneish M-Score : -2.80 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Dian Diagnostics Group Co's Beneish M-Score or its related term are showing as below:

SZSE:300244' s Beneish M-Score Range Over the Past 10 Years
Min: -2.97   Med: -2.14   Max: -1.01
Current: -2.8

During the past 13 years, the highest Beneish M-Score of Dian Diagnostics Group Co was -1.01. The lowest was -2.97. And the median was -2.14.


Dian Diagnostics Group Co Beneish M-Score Historical Data

The historical data trend for Dian Diagnostics Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Beneish M-Score Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.36 -2.61 -2.33 -2.15 -2.84

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.64 -2.95 -2.97 -2.84 -2.80

Competitive Comparison of Dian Diagnostics Group Co's Beneish M-Score

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Beneish M-Score falls into.



Dian Diagnostics Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Dian Diagnostics Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1618+0.528 * 1.1845+0.404 * 1.4154+0.892 * 0.697+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3602+4.679 * -0.095926-0.327 * 0.8421
=-2.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥8,687 Mil.
Revenue was 2973.006 + 3116.125 + 3450.329 + 3610.057 = ¥13,150 Mil.
Gross Profit was 758.955 + 817.656 + 1109.233 + 1184.449 = ¥3,870 Mil.
Total Current Assets was ¥13,467 Mil.
Total Assets was ¥17,855 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,884 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥1,550 Mil.
Total Current Liabilities was ¥4,871 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,556 Mil.
Net Income was 23.17 + -223.418 + 77.586 + 293.019 = ¥170 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was -266.946 + 1554.545 + 338.957 + 256.578 = ¥1,883 Mil.
Total Receivables was ¥10,727 Mil.
Revenue was 3231.809 + 4652.884 + 4876.447 + 6104.32 = ¥18,865 Mil.
Gross Profit was 1083.599 + 1108.93 + 1780.121 + 2604.485 = ¥6,577 Mil.
Total Current Assets was ¥17,139 Mil.
Total Assets was ¥21,162 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,926 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥1,635 Mil.
Total Current Liabilities was ¥7,324 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,131 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(8686.579 / 13149.517) / (10726.722 / 18865.46)
=0.660601 / 0.568591
=1.1618

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6577.135 / 18865.46) / (3870.293 / 13149.517)
=0.348634 / 0.29433
=1.1845

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (13466.871 + 1884.342) / 17855.213) / (1 - (17138.579 + 1926.246) / 21161.555)
=0.140239 / 0.099082
=1.4154

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=13149.517 / 18865.46
=0.697

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1926.246)) / (0 / (0 + 1884.342))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1549.863 / 13149.517) / (1634.79 / 18865.46)
=0.117865 / 0.086655
=1.3602

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2556.435 + 4871.369) / 17855.213) / ((3130.784 + 7323.508) / 21161.555)
=0.416002 / 0.494023
=0.8421

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(170.357 - 0 - 1883.134) / 17855.213
=-0.095926

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Dian Diagnostics Group Co has a M-score of -2.80 suggests that the company is unlikely to be a manipulator.


Dian Diagnostics Group Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines